These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

421 related items for PubMed ID: 9753460

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Low-density lipoprotein from apolipoprotein E-deficient mice induces macrophage lipid accumulation in a CD36 and scavenger receptor class A-dependent manner.
    Zhao Z, de Beer MC, Cai L, Asmis R, de Beer FC, de Villiers WJ, van der Westhuyzen DR.
    Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):168-73. PubMed ID: 15514202
    [Abstract] [Full Text] [Related]

  • 23. Hypertriglyceridemia: lipoprotein receptors and atherosclerosis.
    Gianturco SH, Gotto AM, Bradley WA.
    Adv Exp Med Biol; 1985 Jan; 183():47-71. PubMed ID: 4036704
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Hypertriglyceridemic very low density lipoproteins induce triglyceride synthesis and accumulation in mouse peritoneal macrophages.
    Gianturco SH, Bradley WA, Gotto AM, Morrisett JD, Peavy DL.
    J Clin Invest; 1982 Jul; 70(1):168-78. PubMed ID: 6282937
    [Abstract] [Full Text] [Related]

  • 26. Differential metabolism of human VLDL according to content of ApoE and ApoC-III.
    Tomiyasu K, Walsh BW, Ikewaki K, Judge H, Sacks FM.
    Arterioscler Thromb Vasc Biol; 2001 Sep; 21(9):1494-500. PubMed ID: 11557678
    [Abstract] [Full Text] [Related]

  • 27. Cholesteryl ester accumulation in mouse peritoneal macrophages induced by beta-migrating very low density lipoproteins from patients with atypical dysbetalipoproteinemia.
    Bersot TP, Innerarity TL, Mahley RW, Havel RJ.
    J Clin Invest; 1983 Sep; 72(3):1024-33. PubMed ID: 6309903
    [Abstract] [Full Text] [Related]

  • 28. Heterogeneous properties of intermediate- and low-density lipoprotein subpopulations.
    Srisawasdi P, Vanavanan S, Rochanawutanon M, Pornsuriyasak P, Tantrakul V, Kruthkul K, Kotani K.
    Clin Biochem; 2013 Oct; 46(15):1509-15. PubMed ID: 23830843
    [Abstract] [Full Text] [Related]

  • 29. Interaction of very-low-density, intermediate-density, and low-density lipoproteins with human arterial wall proteoglycans.
    Anber V, Millar JS, McConnell M, Shepherd J, Packard CJ.
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2507-14. PubMed ID: 9409221
    [Abstract] [Full Text] [Related]

  • 30. 2-Aminopurine inhibits lipid accumulation induced by apolipoprotein E-deficient lipoprotein in macrophages: potential role of eukaryotic initiation factor-2alpha phosphorylation in foam cell formation.
    Wu D, Yang H, Zhao Y, Sharan C, Goodwin JS, Zhou L, Guo Y, Guo Z.
    J Pharmacol Exp Ther; 2008 Aug; 326(2):395-405. PubMed ID: 18463320
    [Abstract] [Full Text] [Related]

  • 31. Metabolism of very-low-density lipoprotein and low-density lipoprotein containing apolipoprotein C-III and not other small apolipoproteins.
    Mendivil CO, Zheng C, Furtado J, Lel J, Sacks FM.
    Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):239-45. PubMed ID: 19910636
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Effects of the cholesteryl ester transfer protein inhibitor torcetrapib on apolipoprotein B100 metabolism in humans.
    Millar JS, Brousseau ME, Diffenderfer MR, Barrett PH, Welty FK, Faruqi A, Wolfe ML, Nartsupha C, Digenio AG, Mancuso JP, Dolnikowski GG, Schaefer EJ, Rader DJ.
    Arterioscler Thromb Vasc Biol; 2006 Jun; 26(6):1350-6. PubMed ID: 16574893
    [Abstract] [Full Text] [Related]

  • 35. Apolipoprotein E is the determinant that mediates the receptor uptake of beta-very low density lipoproteins by mouse macrophages.
    Innerarity TL, Arnold KS, Weisgraber KH, Mahley RW.
    Arteriosclerosis; 1986 Jun; 6(1):114-22. PubMed ID: 3942555
    [Abstract] [Full Text] [Related]

  • 36. Stimulation of cholesteryl ester synthesis in mouse peritoneal macrophages by cholesterol-rich very low density lipoproteins from the Watanabe heritable hyperlipidemic rabbit, an animal model of familial hypercholesterolemia.
    Kita T, Yokode M, Watanabe Y, Narumiya S, Kawai C.
    J Clin Invest; 1986 May; 77(5):1460-5. PubMed ID: 3700648
    [Abstract] [Full Text] [Related]

  • 37. Triglyceride-rich lipoproteins isolated by selected-affinity anti-apolipoprotein B immunosorption from human atherosclerotic plaque.
    Rapp JH, Lespine A, Hamilton RL, Colyvas N, Chaumeton AH, Tweedie-Hardman J, Kotite L, Kunitake ST, Havel RJ, Kane JP.
    Arterioscler Thromb; 1994 Nov; 14(11):1767-74. PubMed ID: 7947602
    [Abstract] [Full Text] [Related]

  • 38. Pitavastatin inhibits remnant lipoprotein-induced macrophage foam cell formation through ApoB48 receptor-dependent mechanism.
    Kawakami A, Tani M, Chiba T, Yui K, Shinozaki S, Nakajima K, Tanaka A, Shimokado K, Yoshida M.
    Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):424-9. PubMed ID: 15591219
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. The actin cytoskeleton is important for the stimulation of cholesterol esterification by atherogenic lipoproteins in macrophages.
    Tabas I, Zha X, Beatini N, Myers JN, Maxfield FR.
    J Biol Chem; 1994 Sep 09; 269(36):22547-56. PubMed ID: 8077203
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.